Tempus AI is a healthcare-oriented artificial intelligence company. Spruce Point Capital Management released a report ...

For context, Tempus uses AI to improve precision medicine solutions, as well as drug discovery and diagnostics. Its operating ...

BFLY outpaces TEM with stronger upside, leaner valuation, and expanding global reach in AI-powered diagnostics.

Tempus AI stock is trading at a nosebleed valuation, and despite the compelling long-term upside, it's not worth investing at ...

Tempus AI delivered strong Q1 results, driven by the Ambry Genetics acquisition and a major AstraZeneca contract, boosting ...

In this video, I will talk about Tempus AI (NASDAQ: TEM) and the recent short-seller report. Watch the short video to learn more, consider subscribing, and click the special offer link below. *Stock ...

U.S.-based Tempus AI came under intense pressure after a scathing short seller report raised red flags about the company’s valuation, business model, and financial transparency.

Spruce Point said Tempus’ revenue quality should be carefully scrutinized, because of signs of "aggressive accounting." ...

Spruce Point Capital Management has announced a new short position against Tempus AI Inc (NASDAQ:TEM). The short seller on ...

Just consider the source, and the fact that Spruce Point has something to gain by Tempus AI stock's pullback. If the name rings a bell, it may be because California Representative Nancy Pelosi ...